Status:
UNKNOWN
Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load
Lead Sponsor:
Beijing Ditan Hospital
Conditions:
Immune Globulin, Prophylaxis, Telbuvidine, Vaccine
Eligibility:
All Genders
Up to 7 years
Brief Summary
Mother-to-child transmission (MTCT) is the most common route of hepatitis B virus (HBV) infection. After given standard immunoprophylaxis, MTCT still occurred in some infants born to a HBsAg positive ...
Detailed Description
This study contain 600 patients and compose groups as follow: (ⅰ) infants born to a HBsAg positive mothers with high HBV DNA load before delivery receive standard immunoprophylaxis( injection of HBIG ...
Eligibility Criteria
Inclusion
- infants born to HBsAg positive mother HBsAg positive mother
Exclusion
- mothers coinfected HIV or HCV
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT02253485
Start Date
August 1 2012
End Date
December 1 2015
Last Update
October 1 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.